Supplements

Rigid targets and invasive algorithms in intensive care medicine often add little once high-quality usual care is established

This historical review of landmark ICU trials found that protocol-driven approaches improved timeliness and consistency, but later pragmatic trials showed that rigid targets and invasive algorithms often added little benefit when high-quality usual care was already in place. The review emphasizes that modern trials have clarified not only what works, but what can be reduced, delayed, avoided, or applied selectively.

Last updated: Aug 19, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Decades of intensive care medicine trials: what randomised evidence has changed, corrected, and still questions to resolve.

observational

Martin-Loeches I, Leone M, Coopersmith CM, Machado FR, Hodgson C, Calfee CS, Schultz MJ · Intensive care medicine (2026)

Participants: N/A
Duration: N/A
Intervention: Rigid protocol-driven targets and invasive algorithms versus high-quality usual care
Outcome: Patient-centred outcomes (e.g., survival, recovery, long-term function)
Effect Size: N/A
Population: Adult intensive care unit patients across various conditions (sepsis, ARDS, etc.)

Result:

PubMed: 42593537DOI: 10.1007/s00134-026-08579-z

Mechanism Graph

Early biological and haemodynamic trials exposed limits of reductionist strategies in syndromic critical illness
↓
Protocol-driven approaches improved timeliness and consistency
↓
Later pragmatic trials showed rigid targets and invasive algorithms added little once high-quality usual care was established
↓
Result: Emphasis on timing, disease phase, baseline risk, heterogeneity, patient selection, and treatment-related harm

Limitations

  • ⚠This is an interpretive historical review, not a systematic review or meta-analysis, so selection of trials may be subjective
  • ⚠The review covers trials from early 1990s onwards, and findings may not generalize to newer interventions or evolving usual care standards

Frequently Asked Questions

What is the main takeaway from this review of ICU trials?▼

The main takeaway is that many interventions with strong physiological rationale failed to improve patient outcomes, while optimizing supportive care, avoiding iatrogenic harm, and reassessing established practices led to durable advances. Rigid protocols may not outperform high-quality usual care.

Does this mean protocols are not useful in intensive care?▼

No, the review notes that protocol-driven approaches improved timeliness and consistency, but later trials showed that rigid targets and invasive algorithms often added little once high-quality usual care was established. The key is to apply protocols selectively based on patient context.

What areas of intensive care were covered in this review?▼

The review covered haemodynamic support, mechanical ventilation, renal replacement therapy, antimicrobial treatment, nutrition, glucose control, transfusion, and sedation.

What future direction does the review suggest for ICU research?▼

Future progress requires biologically informed, context-sensitive trials focused on meaningful survival, recovery, and long-term function, rather than just therapeutic expansion.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Martin-Loeches I, Leone M, Coopersmith CM, Machado FR, Hodgson C, Calfee CS, Schultz MJ. "Decades of intensive care medicine trials: what randomised evidence has changed, corrected, and still questions to resolve.." Intensive care medicine, 2026. PMID: 42593537 DOI: 10.1007/s00134-026-08579-z
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.